Company intelligence / Profile preview

pharmtrace

Ownership: Private
Employees: ~25
Development stage: Commercial

Overview

pharmtrace is an independent German-based CRO specializing in medical imaging, radiopharmaceuticals, and radiological procedures for clinical trials. It provides consulting, site management, central image assessment, data analysis services, and operates the GCP-compliant ERICA platform to support robust regulatory submissions. The company has supported programs leading to marketing authorizations since its founding in 2006. It serves biotech firms, academia, pharmaceutical companies globally from offices in Berlin and Philadelphia.

Therapeutic areas: Cardiovascular
Modalities: RadiopharmaceuticalsImaging agents
Industry: Contract Research Organization

Partnerships

Alzeca Biosciences Inc.Member of Competence Network Life Sciences (“CONELIS”)

Beyond the preview

Go deeper on pharmtrace.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on pharmtrace.

Explore the full profile